Intel Stock Shot Again: Why Shares Jumped in May This Year
A renewed wave of interest in AI hardware helped propel Intel shares higher in May. This article digs into the driver...
What Retirement Accounts Should I Use At 50
Learn what retirement accounts you should use at 50. Choosing wisely can secure your financial freedom.
25,328 articlesStock Market Today, June: Marvell Surges After S&P 500 Inclusion
Marvell Technology jumped on news it will join the S&P 500, triggering bullish moves in chips and AI infrastructure p...
Samsung, Hynix, and Micron Fighting for AI Memory Dominance
AI memory demand is reshaping a sleepy sector. Learn how to gain exposure to Samsung, Hynix, and Micron with a smart,...
Spacex's Fundraising Over with a $20 Billion Bond Offering
SpaceX just shook the investor world again with a massive bond offering. This article breaks down what spacex's fundr...
Dyne Therapeutics vs Viking Therapeutics: 2026 Buy Guide
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Anthropic Could Trillion This Fall: AI IPO Insight
Anthropic’s looming IPO could reshape AI investing. With a private valuation near the hundreds of billions and big te...
Investors Growing Wary AI-Related Debt: Risks and Radar
AI champions are racing to fund data centers, but the debt that fuels this surge is drawing scrutiny. This guide expl...
Omnicom (OMC) 2025 Earnings Outlook: Ad Market Shifts
As Omnicom wraps up the 2025 fiscal year, investors want clarity on growth, margins, and capital allocation. This gui...
Why Oneok Fell Today: Key Takeaways for Investors
Oneok beat quarterly expectations but issued soft 2026 guidance, sending shares lower. This article explains why oneo...
UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
GLP-1s Cure Hunger More, Study Finds Broad Impact
A sweeping real-world study of roughly 600,000 GLP-1 users finds cravings for cigarettes, alcohol, and other addictio...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status